U.S. markets close in 2 hours 50 minutes

As Convalescent Plasma is Authorized for Use as a Treatment Against COVID-19 in the US and China, Blood Banks Call for Donations

DUBLIN, June 22, 2020 /PRNewswire/ -- ResearchAndMarkets.com has published a new article on the blood banks industry "Blood Banks Call for Donations of Convalescent Plasma to Fight COVID-19"

Research and Markets Logo

Stay-at-home orders and the cancellation of elective surgeries have led to a reduced demand for blood and blood products. However, as countries begin to lift lockdown restrictions and allow elective surgeries to take place there will be a surge in demand for blood and some hospitals are worried about their supplies. Although in many cases blood drives were exempt from bans on mass gatherings, many had to be suspended due to the closures of schools, colleges and businesses. This has led to shortages of blood in some areas. In response to the growing need for blood, many donation centers are remaining open to donations by appointment to facilitate social-distancing.

The FDA is also encouraging people who have recovered from COVID-19 to donate their blood plasma for use as a treatment for patients who are severely affected. This convalescent plasma contains antibodies against the virus and can help patients to fight off the infection. Convalescent plasma has been authorized for use as a treatment against COVID-19 in the US as well as in Austria, France, Switzerland and China. Previous studies have shown it to be effective against infectious diseases like SARS and Ebola. In the US, blood centers like Bloodworks Northwest, Vitalant and America's Blood Centers have mobilized to collect convalescent plasma donations.

ResearchAndMarkets.com offer a wide range of reports that cover the above topic, across all geographic markets.

To see the full article and a list of related reports on the market, visit"Blood Banks Call for Donations of Convalescent Plasma to Fight COVID-19"

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision

View original content:http://www.prnewswire.com/news-releases/as-convalescent-plasma-is-authorized-for-use-as-a-treatment-against-covid-19-in-the-us-and-china-blood-banks-call-for-donations-301081192.html

SOURCE Research and Markets